Supply Issue – Risperidone (Teva) 0.5mg tablets and Risperidone (Teva) 2mg tablets

There is currently a supply disruption affecting risperidone (Teva) 0.5 mg and 2 mg tablets. This is due to an issue at the manufacturer.

To support continuity of care, from 1 June, Pharmac will list (fund) alternative products, Risperidone Sandoz 0.5 mg tab and Risperidone Sandoz 2 mg tab.

Please note Risperidone Sandoz tablets are not Medsafe‑approved and must therefore be prescribed and supplied in accordance with Section 29A of the Medicines Act.

Further information about this supply issue will be added to our webpage as updates become available - Risperidone (0.5 mg and 2 mg tablets): Supply issue

Please share this information - Please share this information with your colleagues and within your networks.

If you have any questions regarding this supply issue, please contact enquiry@pharmac.govt.nz.

Ngā mihi

Dr David Hughes

David Hughes

Chief Medical Officer | Director Advice & Assessment

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

DDI: +64 21 962 317 | P: +64 4 460 4990 |  www.pharmac.govt.nz